Your browser doesn't support javascript.
loading
Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis.
Jonstam, Karin; Swanson, Brian N; Mannent, Leda P; Cardell, Lars-Olaf; Tian, Nian; Wang, Ying; Zhang, Donghui; Fan, Chunpeng; Holtappels, Gabriele; Hamilton, Jennifer D; Grabher, Annette; Graham, Neil M H; Pirozzi, Gianluca; Bachert, Claus.
Afiliación
  • Jonstam K; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
  • Swanson BN; Department of Ear, Nose and Throat Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Mannent LP; Sanofi, Bridgewater, New Jersey.
  • Cardell LO; Sanofi, Chilly-Mazarin, France.
  • Tian N; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
  • Wang Y; Department of Ear, Nose and Throat Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Zhang D; Sanofi, Bridgewater, New Jersey.
  • Fan C; Sanofi, Bridgewater, New Jersey.
  • Holtappels G; Sanofi, Bridgewater, New Jersey.
  • Hamilton JD; Sanofi, Bridgewater, New Jersey.
  • Grabher A; Upper Airways Research Laboratory, Ghent University Hospital, Ghent, Belgium.
  • Graham NMH; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Pirozzi G; Sanofi, Berlin, Germany.
  • Bachert C; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
Allergy ; 74(4): 743-752, 2019 04.
Article en En | MEDLINE | ID: mdl-30488542
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sinusitis / Rinitis / Pólipos Nasales / Anticuerpos Monoclonales Humanizados / Inflamación Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Allergy Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sinusitis / Rinitis / Pólipos Nasales / Anticuerpos Monoclonales Humanizados / Inflamación Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Allergy Año: 2019 Tipo del documento: Article